Mironid
5 known investors
Mironid is a drug development company building a pipeline of therapies targeting cAMP-degrading phosphodiesterase enzymes to treat Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney diseases. It focuses on developing novel therapeutics for rare diseases with high unmet clinical need.
Founders & leadership
AR
Adele RowleyChief Scientific Officer
Investors · 5
Competitors · 5
by search overlap
Rif Care7 shared keywordsRif Care is a menstrual care brand offering plant-based period products.
Medpagetoday7 shared keywordsMedPage Today publishes medical news, clinical research coverage, meeting reports, and physician-focused opinion across specialties such as cardiology, endocrinology, and pulmonology. It serves healthcare professionals, including physicians and nurses, with breaking medical news and continuing coverage.
Womenshealthmag7 shared keywordsWomen's Health is a media brand publishing articles, guides, podcasts, and video series on fitness, nutrition, beauty, and health topics aimed at women. It also offers subscription-based (WH+) workout and nutrition plans covering strength training, muscle building, and longevity.
Today7 shared keywordsTODAY is a media outlet publishing news and lifestyle content across food, recipes, health and wellness, parenting, pop culture, books, and relationships. It also offers Start TODAY, a subscription fitness and wellness membership with workouts, meal plans, and expert support.
The Lanby7 shared keywordsThe Lanby is a membership-based medical practice combining primary care, functional medicine, and longevity services delivered by a multidisciplinary care team (physician, dietitian, nurse practitioner, and member advocate) under a single plan. It serves individual patients seeking proactive, preventive healthcare and is based in New York City.
Companies competing with Mironid for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Mironid do?
- Mironid is a drug development company building a pipeline of therapies targeting cAMP-degrading phosphodiesterase enzymes to treat Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney diseases. It focuses on developing novel therapeutics for rare diseases with high unmet clinical need.
- Who are Mironid's investors?
- Mironid's investors include Epidarex Capital, Roche Venture Fund, Sofinnova Partners, BioGeneration Ventures, Scottish National Investment Bank.